Previous 10 | Next 10 |
One million prescriptions for AspyreRx will be offered to patients in underserved communities disproportionately affected by type 2 diabetes Better Therapeutics, Inc. (NASDAQ: BTTX), a pioneer in developing prescription digital therapeutics (PDTs) for treating cardiometabolic diseas...
Company to host sponsored education session on Saturday, March 09, 2024; Expanding access to a high quality and effective lifestyle modification intervention Better Therapeutics, Inc. (NASDAQ: BTTX), a pioneer in developing prescription digital therapeutics (PDTs) for treating cardi...
ORLANDO, FL / ACCESSWIRE / March 1, 2024 / RedChip Companies will air interviews with Better Therapeutics, Inc. (Nasdaq:BTTX) and Biotricity, Inc. (Nasdaq:BTCY) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this Saturday, March 2, at 7 p.m. Eastern T...
Signifies the FDA’s recognition of the Company’s novel Cognitive Behavioral Therapy as a potential treatment for metabolic dysfunction-associated steatohepatitis Opens an accelerated path towards a potential second indication Better Therapeutics, Inc. (NASDAQ: ...
Agreement is an important step towards securing broad coverage Better Therapeutics Inc. (NASDAQ: BTTX), a pioneer in developing prescription digital therapeutics (PDTs) for treating cardiometabolic diseases, today announced that it has entered into a rebate agreement with one of the...
Better Therapeutics Inc. (NASDAQ: BTTX), a pioneer in developing prescription digital therapeutics (PDTs) for treating cardiometabolic diseases, and Glooko, Inc. , a global leader in chronic condition management, today announced a partnership to integrate Better Therapeutics’ Aspyr...
2024-01-02 10:08:42 ET More on Better Therapeutics Better Therapeutics, Inc. (BTTX) Q3 2023 Earnings Call Transcript Better Therapeutics, Inc. 2023 Q3 - Results - Earnings Call Presentation Better Therapeutics amends debt facility, implements cost-saving measures ...
Better Therapeutics, Inc. (NASDAQ: BTTX), a pioneer in developing prescription digital therapeutics (PDTs) to treat cardiometabolic diseases, today announced it has submitted a request to the U.S. Food and Drug Administration (FDA) for Breakthrough Device Designation for its novel PDT designed ...
2023-12-13 17:34:11 ET More on Better Therapeutics Better Therapeutics amends debt facility, implements cost-saving measures Seeking Alpha’s Quant Rating on Better Therapeutics Historical earnings data for Better Therapeutics For further details see: ...
2023-11-28 08:49:38 ET More on Better Therapeutics Better Therapeutics, Inc. (BTTX) Q3 2023 Earnings Call Transcript Better Therapeutics, Inc. 2023 Q3 - Results - Earnings Call Presentation Seeking Alpha’s Quant Rating on Better Therapeutics Historical...
News, Short Squeeze, Breakout and More Instantly...
Better Therapeutics Inc. Company Name:
BTTX Stock Symbol:
OTCMKTS Market:
Better Therapeutics Inc. Website:
DS Smith Plc. (DITHF) is expected to report for Q4 2024 Bluegreen Vacations Holding Corporation - Class B (BVHBB) is expected to report for Q1 2024 Harbour Energy Plc ADR (HBRIY) is expected to report for Q1 2024 Bayerische Motoren Werke AG (BAMXF) is expected to report for Q1 2024 ...
Commercial Metals Company (CMC) is expected to report $1 for Q3 2024 CREATD INC. (CRTD) is expected to report for Q1 2024 GMS Inc. (GMS) is expected to report $2.04 for Q4 2024 China Jo-Jo Drugstores Inc. (CJJD) is expected to report for Q4 2024 Eiger BioPharmaceuticals Inc. (EIGR...
Usinas Siderurgicas De Minas Gerais S.A. ADR (Representing Pref Share Cl A) (USNZY) is expected to report $0 for Q2 2024 CREATD INC. (CRTD) is expected to report for Q1 2024 Bluegreen Vacations Holding Corporation - Class B (BVHBB) is expected to report for Q1 2024 Senstar Technologie...